ATE482957T1 - Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel - Google Patents

Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel

Info

Publication number
ATE482957T1
ATE482957T1 AT06819000T AT06819000T ATE482957T1 AT E482957 T1 ATE482957 T1 AT E482957T1 AT 06819000 T AT06819000 T AT 06819000T AT 06819000 T AT06819000 T AT 06819000T AT E482957 T1 ATE482957 T1 AT E482957T1
Authority
AT
Austria
Prior art keywords
arylestic
acid
inflammatory agents
ester derivatives
derivatives
Prior art date
Application number
AT06819000T
Other languages
English (en)
Inventor
Lyndon Nigel Brown
Catherine Leblanc
David Andrew Sandham
Harinder Pal Singh
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE482957T1 publication Critical patent/ATE482957T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06819000T 2005-12-09 2006-12-07 Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel ATE482957T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0525144.2A GB0525144D0 (en) 2005-12-09 2005-12-09 Organic compounds
PCT/EP2006/011770 WO2007065683A1 (en) 2005-12-09 2006-12-07 Aryl acetic acid and ester derivatives and their uses as antiinflammatory

Publications (1)

Publication Number Publication Date
ATE482957T1 true ATE482957T1 (de) 2010-10-15

Family

ID=35735863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06819000T ATE482957T1 (de) 2005-12-09 2006-12-07 Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel

Country Status (17)

Country Link
US (1) US20080312229A1 (de)
EP (1) EP1960398B1 (de)
JP (1) JP2009518343A (de)
KR (1) KR20080065699A (de)
CN (1) CN101326185A (de)
AR (1) AR056887A1 (de)
AT (1) ATE482957T1 (de)
AU (1) AU2006322206B2 (de)
BR (1) BRPI0619529A2 (de)
CA (1) CA2630611A1 (de)
DE (1) DE602006017256D1 (de)
GB (1) GB0525144D0 (de)
PE (1) PE20071035A1 (de)
PT (1) PT1960398E (de)
RU (1) RU2008127439A (de)
TW (1) TW200732337A (de)
WO (1) WO2007065683A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144903A (en) 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
GB0525143D0 (en) * 2005-12-09 2006-01-18 Novartis Ag Organic compounds
CA2658986C (en) 2006-08-07 2014-11-25 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
WO2009093029A1 (en) * 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
BR112012018695A2 (pt) * 2010-01-27 2016-04-12 Boehringer Ingelheim Int compostos pirazol como antagonistas crth2
CN102791689B (zh) 2010-03-22 2014-10-29 埃科特莱茵药品有限公司 3-（杂芳基-氨基）-1,2,3,4-四氢-9h-咔唑衍生物及其作为前列腺素d2受体调节剂的用途
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
SG10201913594UA (en) 2010-04-22 2020-02-27 Vertex Pharma Process of producing cycloalkylcarboxamido-indole compounds
EP2457900A1 (de) 2010-11-25 2012-05-30 Almirall, S.A. Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
MX338516B (es) 2011-04-14 2016-04-20 Actelion Pharmaceuticals Ltd Derivados de acido 7- (heteroaril-amino) -6, 7, 8, 9- tetrahidropirido[1,2-a] indol acetico y sus usos como modulador del receptor de prostaglandina.
DK2781508T3 (en) 2011-11-17 2019-03-11 Kbp Biosciences Co Ltd NITROGEN CONCENTRATED RING COMPOUNDS FOR USE AS CRTH2 ANTAGONISTS
MX384987B (es) 2014-03-17 2025-03-14 Idorsia Pharmaceuticals Ltd Derivados del ácido acético azaindol y su uso como moduladores de receptor de prostaglandina d2.
EP3119780B1 (de) 2014-03-18 2018-08-29 Idorsia Pharmaceuticals Ltd Azaindolessigsäurederivate und deren verwendung als prostaglandin-d2-rezeptormodulatoren
MX387720B (es) 2014-04-15 2025-03-12 Vertex Pharma Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de conductancia de transmembrana de fibrosis quística.
JP6833852B2 (ja) 2015-09-15 2021-02-24 イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ 結晶形
RU2020118594A (ru) 2017-11-06 2021-12-09 Рапт Терапьютикс, Инк. Противораковые агенты

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320268A (en) * 1964-08-14 1967-05-16 Merck & Co Inc 1-aroyl or heteroaroyl-7-azaindole-3-carboxylates and derivatives
ES2551929T3 (es) * 2003-02-06 2015-11-24 Dompé Farmaceutici S.P.A. Ácidos 2-arilacéticos, sus derivados y composiciones farmacéuticas que los contienen
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists

Also Published As

Publication number Publication date
EP1960398A1 (de) 2008-08-27
AU2006322206A1 (en) 2007-06-14
DE602006017256D1 (de) 2010-11-11
KR20080065699A (ko) 2008-07-14
CA2630611A1 (en) 2007-06-14
CN101326185A (zh) 2008-12-17
AR056887A1 (es) 2007-10-31
EP1960398B1 (de) 2010-09-29
WO2007065683A1 (en) 2007-06-14
PE20071035A1 (es) 2007-10-30
JP2009518343A (ja) 2009-05-07
TW200732337A (en) 2007-09-01
PT1960398E (pt) 2010-11-26
RU2008127439A (ru) 2010-01-20
US20080312229A1 (en) 2008-12-18
GB0525144D0 (en) 2006-01-18
AU2006322206B2 (en) 2010-08-19
BRPI0619529A2 (pt) 2011-10-04

Similar Documents

Publication Publication Date Title
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
ATE378338T1 (de) Pyrrolopyridinderivate und deren verwendung als crth2-antagonisten
ATE482957T1 (de) Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel
EP2131848A4 (de) Zusammensetzungen und verfahren für verstärkte aktivität von biologisch aktiven molekülen
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ATE342258T1 (de) N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel
DE602005015699D1 (de) Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
DE602005022116D1 (de) 5-heteroarylthiazole und deren verwendung als pi3k-inhibitoren
DE602005004144D1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mitteln
DE602006020330D1 (de) Pyridazinverbindung und deren verwendung
DE602006012060D1 (de) Bicyclische bisamidderivate und deren anwendung als insektizide
ATE517081T1 (de) Hydroxamsäureester und deren pharmazeutische verwendung
ATE519744T1 (de) 1h-pyrazol-4-carbonsäure-amide, deren herstellung und verwendung als 11-beta-hydroxysteroid- dehydrogenase-hemmer
DE502007001209D1 (de) Wachszusammensetzung und deren Verwendung
ATE472549T1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel
DK1868586T3 (da) Antiinflammatorisk formulering
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
DE602006020993D1 (de) Difluorbenzolderivat und darauf basierende nematisch flüssigkristalline zusammensetzung
DE602004008668D1 (de) Benzoxazinderivate und deren verwendungen
ATE396185T1 (de) Substituierte 4-alkyl- und 4- alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten
DE602007006540D1 (de) Cyclopropancarboxylate und deren verwendung als pestizide
ATE517098T1 (de) Acylaminothiazolderivate und deren verwendung als beta-amyloid-inhibitoren
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
DE602005022060D1 (de) Diaminoalkohole und deren verwendung als renininhibitoren
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties